Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Milne

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Pharmacoeconomics|September 5, 1994
Evaluation of the pharmacoeconomic literatureR J Milne
Pharmacoeconomics|January 6, 2000
Communication of socioeconomic research findingsR J Milne
Molecular Pharmacology|March 1, 1981
Effects of hexamethonium and decamethonium on end-plate current parametersR J Milne, J H Byrne
Brain Research|June 25, 1990
Behavioural modification of bulbospinal serotonergic inhibition and morphine analgesiaR J Milne, G D Gamble
Neuroscience Letters|January 30, 1989
Repeated exposure to sham testing procedures reduces reflex withdrawal and hot-plate latencies: attenuation of tonic descending inhibition?G D Gamble, R J Milne
Pharmacoeconomics|September 5, 1992
Ondansetron: a pharmacoeconomic and quality-of-life evaluation of its antiemetic activity in patients receiving cancer chemotherapyG L Plosker, R J Milne
Drugs|March 1, 1991
Citalopram. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illnessR J Milne, K L Goa
Drugs|April 1, 1991
Ondansetron. Therapeutic use as an antiemeticR J Milne, R C Heel
Drugs|June 1, 1991
Celiprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in cardiovascular diseaseR J Milne, M M Buckley
Brain Research|April 30, 1990
Hypercapnia depresses nociception: endogenous opioids implicatedG D Gamble, R J Milne
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Pharmacoeconomics|September 5, 1994
Evaluation of the pharmacoeconomic literatureR J Milne
Pharmacoeconomics|January 6, 2000
Communication of socioeconomic research findingsR J Milne
Molecular Pharmacology|March 1, 1981
Effects of hexamethonium and decamethonium on end-plate current parametersR J Milne, J H Byrne
Brain Research|June 25, 1990
Behavioural modification of bulbospinal serotonergic inhibition and morphine analgesiaR J Milne, G D Gamble
Neuroscience Letters|January 30, 1989
Repeated exposure to sham testing procedures reduces reflex withdrawal and hot-plate latencies: attenuation of tonic descending inhibition?G D Gamble, R J Milne
Pharmacoeconomics|September 5, 1992
Ondansetron: a pharmacoeconomic and quality-of-life evaluation of its antiemetic activity in patients receiving cancer chemotherapyG L Plosker, R J Milne
Drugs|March 1, 1991
Citalopram. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illnessR J Milne, K L Goa
Drugs|April 1, 1991
Ondansetron. Therapeutic use as an antiemeticR J Milne, R C Heel
Drugs|June 1, 1991
Celiprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in cardiovascular diseaseR J Milne, M M Buckley
Brain Research|April 30, 1990
Hypercapnia depresses nociception: endogenous opioids implicatedG D Gamble, R J Milne
Pageof 4